Stem cells take on Huntington's: new trial shows promise
Disease control
Completed
This study tested a stem-cell treatment called Cellavita HD in 49 adults with Huntington's disease. Participants received one of two doses or a placebo, and researchers tracked changes in motor skills over time. The goal was to see if the therapy could slow down the worsening of …
Phase: PHASE2 • Sponsor: Azidus Brasil • Aim: Disease control
Last updated May 26, 2026 09:38 UTC